Array Biopharma Inc (NASDAQ:ARRY)

7.19
Delayed Data
As of Apr 24
 -0.12 / -1.64%
Today’s Change
2.98
Today|||52-Week Range
8.59
+52.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.0B

Company Description

Array BioPharma Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline focuses on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. It also collaborates with pharmaceutical and biotechnology companies under which the firm has out-licensed certain proprietary drug programs for further research, development, and commercialization. The company was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Contact Information

Array BioPharma, Inc.
3200 Walnut Street
Boulder Colorado 80301
P:(303) 381-6600
Investor Relations:
(303) 386-1193

Employees

Shareholders

Other institutional52.47%
Mutual fund holders37.45%
Individual stakeholders14.40%

Top Executives

Ron SquarerChief Executive Officer & Director
Andrew R. RobbinsChief Operating Officer
David J. HorinChief Financial Officer
Nick A. SaccomanoChief Scientific Officer
Robert E. WinklerVice President-Clinical Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account